Current Status
Not Enrolled
Price
$39.95
Get Started

Over the past two decades, studies conducted in the area of omega-3s and mood health have increased exponentially. The benefits uncovered by this research relate specifically to issues such as depression, anxiety and behavior — at all ages. In this webinar, we’ll discuss the latest research on omega-3s and omega-3 blood levels and how you can use this information to guide your patients on the best ways to use these important nutrients to support their mood health.

Course Overview:

  • Why and how omega-3s are beneficial for depression, anxiety and behavior
  • What the latest research shows for omega-3s and mood health, especially how blood levels (i.e. the Omega-3 Index) play a role
  • Why you should test omega-3 levels in your patients who might be having mood health issues like depression, anxiety and ADHD
  • Appropriate omega-3 dosing for your patients
  • How often to test omega-3 status in your patients

 This webinar is approved for 1.0 CEU hours from CDR for RDs and DTRs

Course Leader:

Kristina Harris Jackson, PhD, RD, Chief Operating Officer, OmegaQuant

Kristina Harris Jackson, PhD, RD, is the Chief Operating Officer and part-owner of OmegaQuant Analytics, LLC, and an Assistant Professor (non-tenure) in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine.

Kristina received her PhD in Nutritional Sciences from Pennsylvania State University in 2013 and completed her training to become a Registered Dietitian in 2014. Kristina continues her research in the area of omega-3s in maternal health, helping create the Prenatal DHA test and the Mother’s Milk DHA test.

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.